Tuesday, 23 Apr 2019

You are here

Daniel Lovell, MD: abatacept in JIA

Dr. Daniel Lovell, a pediatric rheumatologist from the University of Cincinnati/Cincinnati Children's Hospital Medical Center discusses a phase-4 study looking at the effectiveness and safety of abatacept in kids with JIA.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

RWCS 2017: Neurobrucellosis, A Case of...

03 Apr 2017

QD Clinic - The Tophi Guy

29 Jan 2019

Dr. Jack Cush at EULAR 2018: The Art of...

14 Jun 2018

Dr. Bill Shergy: Reproductive Health...

24 Oct 2018

Dr. Greg Silverman - The Disconnect...

06 Dec 2016

Dr. Cassie Calabrese: RA Paradigm...

17 Jul 2017

Daniel Lovell, MD: abatacept in JIA

11 Nov 2015

Dr. Janet Pope at EULAR 2018 on Heart...

20 Jun 2018

The RheumNow Week in Review – 21 April...

21 Apr 2017

RheumNow Week in Review – Gout and...

14 Sep 2018

A Video Collage of RheumNow Live 2019

04 Apr 2019

QD Clinic - How to Optimize Methotrexate

07 Mar 2019